Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study
| Autor: | Douma, Li-Anne H, Lalezari, Ferry, van der Noort, Vincent, de Vries, Jeltje F, Monkhorst, Kim, Smesseim, Illaa, Baas, Paul, Schilder, Bodien, Vermeulen, Marrit, Burgers, Jacobus A *, de Gooijer, Cornedine J |
|---|---|
| Zdroj: | In The Lancet Oncology November 2023 24(11):1219-1228 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|